I agree that this site is using cookies. You can find further informations here.
X
Tillotson, Glenn
120  results:
Search for persons X
?
1

Gut microbiome alpha diversity decreases in relation to bod..:

Panzer, Jonathan J. ; Maples, Catherine ; Meyer, Monica P....
American Journal of Infection Control.  52 (2024)  6 - p. 707-711 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Bacteroides and related species: The keystone taxa of the h..:

Shin, Jae Hyun ; Tillotson, Glenn ; MacKenzie, Tiffany N....
Anaerobe.  85 (2024)  - p. 102819 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Efficacy and Health-Related Quality of Life Impact of Fecal..:

Feuerstadt, Paul ; Allegretti, Jessica R. ; Dubberke, Erik R....
Infectious Diseases and Therapy.  13 (2024)  1 - p. 221-236 , 2024
Link: https://doi.org/10.1007/..
 
?
4

Microbiota-Based Live Biotherapeutic Products for Clostridi..:

Monday, Lea ; Tillotson, Glenn ; Chopra, Teena
Infection and Drug Resistance.  17 (2024)  - p. 623-639 , 2024
Link: https://doi.org/10.2147/..
 
?
5

Role of the microbiome in essential metabolism in the human..:

Chopra, Teena ; Hylemon, Phil ; Tillotson, Glenn
Open Forum Infectious Diseases.  10 (2023)  9 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
6

Two-year durability of REBYOTA™ (RBL), a live biotherapeuti..:

Orenstein, Robert ; Hecht, Gail ; Harvey, Adam..
Open Forum Infectious Diseases.  10 (2023)  9 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
7

The burden of CDI in the United States: a multifactorial ch..:

Feuerstadt, Paul ; Theriault, Nicolette ; Tillotson, Glenn
BMC Infectious Diseases.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
8

A narrative review of nontuberculous mycobacterial pulmonar..:

Hamed, Kamal A. ; Tillotson, Glenn
Expert Review of Respiratory Medicine.  17 (2023)  11 - p. 973-988 , 2023
Link: https://doi.org/10.1080/..
 
?
9

Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of an..:

Zeitlinger, Markus ; Tillotson, Glenn ; Echols, Roger
Frontiers in Pharmacology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
10

The Importance of a Broad Consortium of Bacteria for a Heal..:

Tillotson, Glenn ; Vedantam, Gayatri ; Shin, Jae Hyun.
Open Forum Infectious Diseases.  10 (2023)  11 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
11

Gut microbiota and microbiota-based therapies for Clostridi..:

Chopra, Teena ; Hecht, Gail ; Tillotson, Glenn
Frontiers in Medicine.  9 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
12

Fecal Microbiota, Live-jslm for the Prevention of Recurrent..:

Feuerstadt, Paul ; Crawford, Carl V. ; Tan, Xing...
Journal of Clinical Gastroenterology.  , 2023
Link: https://doi.org/10.1097/..
 
?
13

Patient Perception of Route of Rectal Administration of Liv..:

Feuerstadt, Paul ; Oneto, Caterina ; Tillotson, Glenn.
Patient Preference and Adherence.  17 (2023)  - p. 2153-2159 , 2023
Link: https://doi.org/10.2147/..
 
?
14

Economic Impact of Recurrent Clostridioides difficile Infec..:

Reveles, Kelly R. ; Yang, Min ; Garcia-Horton, Viviana...
Advances in Therapy.  40 (2023)  7 - p. 3104-3134 , 2023
Link: https://doi.org/10.1007/..
 
?
15

Transitions of care inClostridioides difficileinfection: a ..:

Khanna, Sahil ; Lett, James ; Lattimer, Cheri.
Therapeutic Advances in Gastroenterology.  15 (2022)  - p. 175628482210786 , 2022
Link: https://doi.org/10.1177/..
 
1-15